Sanofi US News

- During Multiple Myeloma Month Sanofi Genzyme is Reinforcing its Commitment to Help Patients Live with the Second Most Common Blood Cancer in the World -

The makers of Xyzal® Allergy 24HR, now available over-the-counter (OTC) at full prescription strength, are teaming up with Dr. Neeta Ogden to Encourage Allergy Sufferers to 'Wise Up, Rise Up'

Respiratory Syncytial Virus is the most common cause of lung inflammation and pneumonia in infants

- Late-breaking oral abstract to be presented today at the Annual Meeting of the American Academy of Dermatology -

- Praluent continues to be available to patients in the U.S. -

- Antihistamine Offers 24-Hour Relief to Adults and Children with Seasonal and Year-Round Allergies -

Employee holiday drive echoes company’s holistic approach in supporting Monroe County Head Start and Pocono Alliance families

Data also Shows Men Consider Sexual Health to be an Important Priority

- In the MONARCH Study, Sarilumab Monotherapy Demonstrated Superiority Over Adalimumab Monotherapy in Adults with Active Rheumatoid Arthritis -

2016 could be the year of the last case of wild poliomyelitis worldwide

- U.S. adults report issues with sleep, ability to work and feelings of depression and anxiety -

- Data to be presented today during a late breaking abstract session at the 25th Annual European Academy of Dermatology and Venereology (EADV) Congress -